BETA-HAIRPIN PEPTIDOMIMETICS
    51.
    发明申请

    公开(公告)号:US20130189363A1

    公开(公告)日:2013-07-25

    申请号:US13814398

    申请日:2010-08-05

    IPC分类号: C07K7/54

    CPC分类号: C07K7/54 A01N47/44 C07K7/64

    摘要: β-Hairpin peptidomimetics of the general formula Cyclo (-Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11-Xaa12-Xaa13-Xaa14-), enantiomers and pharmaceutically acceptable salts thereof, with Xaa1-Xaa14 being amino acid residues of certain types which are defined in the description and the claims, have anti-infective activity, e.g. to selectively inhibit the growth of or to kill microorganisms such as Bacillus subtilis and/or Shigella boydii. They can be used as medicaments to treat or prevent infections or as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.

    摘要翻译: 通式为Xaa1(-Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11-Xaa12-Xaa13-Xaa14-)的β-发夹肽模拟物,其对映异构体和药学上可接受的盐, -Xaa14是在说明书和权利要求书中定义的某些类型的氨基酸残基,具有抗感染活性,例如, 选择性地抑制枯草芽孢杆菌和/或志贺氏志贺氏杆菌等生长或杀死微生物。 它们可用作治疗或预防感染的药物,或用作食品,化妆品,药​​物或其他含营养材料的消毒剂。 这些肽模拟物可以通过基于混合固相和溶液相合成策略的方法制造。

    PIPERIDINE/PIPERAZINE DERIVATIVES
    53.
    发明申请
    PIPERIDINE/PIPERAZINE DERIVATIVES 有权
    哌啶/哌嗪衍生物

    公开(公告)号:US20100216809A1

    公开(公告)日:2010-08-26

    申请号:US12663009

    申请日:2008-06-05

    摘要: The invention further relates to a DGAT inhibitor of formula (I), including any stereochemically isomeric form thereof, wherein A represents CH or N; the dotted line represents an optional bond in case A represents a carbon atom; X represents —NRx—C(═O)—; —Z—C(═O)—; —Z—NRx—C(═O)—; —S(═O)p-; C(═S)—; —NRx—C(═S)—; —Z—C(═S)—; —Z—NRx—C(═S)—; —O—C(═O)—; —C(═O)—C(═O)—; R1 represents a 5-membered monocyclic heterocycle containing at least 2 heteroatoms; a 6-membered aromatic monocyclic heterocycle; or a 5-membered heterocycle containing at least 2 heteroatoms fused with phenyl, cyclohexyl or a 5-or 6-membered heterocycle; wherein each of said heterocycles may optionally be substituted; R2 represents R3; R3 represents C3-6cycloalkyl, phenyl, naphtalenyl, 2,3-dihydro-1,4-benzodioxinyl, 1,3-benzodioxlyl, 2,3-dihydrobenzofuranyl or a 6-membered aromatic heterocycle containing 1 or 2 N atoms, wherein said C3-6cycloalkyl, phenyl, naphtalenyl, 2,3-dihydro-1,4-benzo-dioxinyl, 1,3-benzodioxolyl, 2,3-dihydrobenzofuranyl or 6-membered aromatic heterocycle may optionally be substituted; a N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof. The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use as a medicine of said compounds.

    摘要翻译: 本发明还涉及式(I)的DGAT抑制剂,其包括其任何立体化学异构形式,其中A表示CH或N; 在A代表碳原子的情况下,虚线代表任意键; X表示-NR x -C(= O) - ; -Z-C(= O) - ; -Z-NRx-C(= O) - ; -S(= O)p-; C(═S) - ; -NR x -C(= S) - ; -Z-C(= S) - ; -Z-NRx-C(= S) - ; -O-C(= O) - ; -C(= O)-C(= O) - ; R1表示含有至少2个杂原子的5元单环杂环; 6元芳族单环杂环; 或含有至少2个与苯基,环己基或5或6元杂环稠合的杂原子的5元杂环; 其中每个所述杂环可任选被取代; R2表示R3; R 3表示C 3-6环烷基,苯基,萘基,2,3-二氢-1,4-苯并二氧杂环己烯基,1,3-苯并二恶唑基,2,3-二氢苯并呋喃基或含1或2个N原子的6元芳族杂环,其中所述C3 6-环烷基,苯基,萘基,2,3-二氢-1,4-苯并二恶基,1,3-苯并二恶唑基,2,3-二氢苯并呋喃基或6-元芳香杂环可以任选被取代; 其N-氧化物,其药学上可接受的盐或其溶剂合物。 本发明还涉及制备这些化合物的方法,包含所述化合物的药物组合物以及用作所述化合物的药物。

    TEMPLATE-FIXED PEPTIDOMIMETICS WITH CXCR7 MODULATING ACTIVITY
    60.
    发明申请
    TEMPLATE-FIXED PEPTIDOMIMETICS WITH CXCR7 MODULATING ACTIVITY 有权
    具有CXCR7调节活性的模板固定化肽

    公开(公告)号:US20130225506A1

    公开(公告)日:2013-08-29

    申请号:US13577143

    申请日:2011-02-04

    IPC分类号: C07K7/64

    摘要: Novel template-fixed β-hairpin peptidomimetics of the general formula (I), wherein the single elements T or P are α-amino acid residues connected from the carbonyl (C═O) point of attachment to the nitrogen (N) of the next element in clockwise direction and wherein said elements, depending on their positions in the chain, are defined in the description and the claims have the property to act on the receptor CXCR7. Thus, these β-hairpin peptidomimetics can be useful in the treatment or prevention of diseases or conditions in the area of dermatological disorders, metabolic diseases, inflammatory diseases, fibrotic diseases, infectious diseases, neurological diseases, cardiovascular diseases, respiratory diseases, gastro-intestinal tract disorders, urological diseases, ophthalmic diseases, stomatological diseases, haematological diseases and cancer; or the mobilisation of stem cells.

    摘要翻译: 通式(I)的新型模板固定β-发夹肽模拟物,其中单个元件T或P是从下述的羰基(C = O)连接点连接到氮(N)的α-氨基酸残基 元件,并且其中所述元件取决于它们在链中的位置在描述中定义,并且权利要求具有作用于受体CXCR7的性质。 因此,这些β-发夹肽模拟物可用于治疗或预防皮肤病,代谢疾病,炎性疾病,纤维化疾病,传染病,神经系统疾病,心血管疾病,呼吸系统疾病,胃肠道疾病或疾病 泌尿系疾病,眼科疾病,口腔病,血液病和癌症; 或干细胞的动员。